Growth Metrics

Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2026)

Teladoc Health's Current Deferred Revenue history spans 8 years, with the latest figure at $65.7 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue fell 21.94% to $65.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $65.7 million, a 21.94% decrease, with the full-year FY2025 number at $62.3 million, down 30.06% from a year prior.
  • Current Deferred Revenue hit $65.7 million in Q1 2026 for Teladoc Health, up from $62.3 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for TDOC hit a ceiling of $121.6 million in Q2 2023 and a floor of $62.3 million in Q4 2025.
  • Historically, Current Deferred Revenue has averaged $97.2 million across 5 years, with a median of $107.2 million in 2024.
  • Biggest five-year swings in Current Deferred Revenue: soared 50.55% in 2022 and later plummeted 30.31% in 2025.
  • Tracing TDOC's Current Deferred Revenue over 5 years: stood at $113.8 million in 2022, then fell by 3.96% to $109.3 million in 2023, then fell by 18.48% to $89.1 million in 2024, then crashed by 30.06% to $62.3 million in 2025, then rose by 5.47% to $65.7 million in 2026.
  • Business Quant data shows Current Deferred Revenue for TDOC at $65.7 million in Q1 2026, $62.3 million in Q4 2025, and $70.1 million in Q3 2025.